These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9381016)

  • 1. [Clinical value of C-peptide determination].
    Meier C; Ladewig A; Keller U; Berger W
    Praxis (Bern 1994); 1997 Aug; 86(34):1289-95. PubMed ID: 9381016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
    Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term course of type I-simulating type II-diabetes mellitus].
    Lohmann D; Verlohren HJ; Borsdorf G; Brunner E; Bierwolf B; Richter HV
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):241-4. PubMed ID: 6391902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J; Bárová H; Hill M; Masek Z
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The utility of postprandial C-peptide evaluation in type 2 diabetes].
    Prando R; Giusti R; Ciuchi E; Giusto M; Melga PL; Cheli V
    Riv Eur Sci Med Farmacol; 1996; 18(3):95-104. PubMed ID: 9213846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus.
    Vlad A; Serban V; Sima A; Timar R; Roşu M
    Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics.
    Laakso M; Sarlund H; Pyörälä K
    Diabetes Res; 1987 Feb; 4(2):95-9. PubMed ID: 3581663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
    Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
    Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
    Gjessing HJ
    Ugeskr Laeger; 1990 Feb; 152(9):588-93. PubMed ID: 2408222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis of insulin- and noninsulin-dependent diabetes mellitus--are there therapeutic implications?].
    Tappy L; Fröhlich FE
    Praxis (Bern 1994); 1994 Dec; 83(50):1406-9. PubMed ID: 7801016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C-peptide levels in secondary sulfonylurea resistant diabetics].
    Balázsi I; Takács J; Hargitai G
    Orv Hetil; 1993 Dec; 134(52):2859-62. PubMed ID: 8272351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes mellitus, but which type?].
    Hoekstra JB; de Koning EJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies between median blood sugar, hemoglobin A, triglycerides and C-peptide in normal-weight insulin and non-insulin dependent diabetics].
    Stradner F; Ulreich A; Zeichen R; Pfeiffer KP
    Wien Med Wochenschr; 1983 Sep; 133(18):459-61. PubMed ID: 6649657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.